LEXICON PHARMACEUTICALS INC
LXRXNASDAQ🏆 #2040 by market capEarnings Nov 4US Equity
$509.44▼ $6.47 (−1.27%)
Simulated price1h—
24h▼ 1.3%
7d—
14d—
30d—
1y—
🏦Market Cap
$1.08B
Small Cap
📈Revenue Growth (YoY)
+60.2%
High Growth
📊Gross Margin
98.8%
High
💵FCF Margin
-192.2%
Thin
⚖️P/S Ratio
26.0x
Expensive
Otter Score
52
Weak
📊
Analyst Ratings
Price
$509.44
Total
14
Raised
2
Lowered
5
Avg PT
$6.00
H / L
$6 / $6
| Institution | Action | Rating | Date |
|---|---|---|---|
Citigroup | Reiterated | Buy | 2026-05-11 |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-23 |
Piper Sandler | Reiterated | Overweight | 2025-03-07 |
Needham | Reiterated | Hold | 2025-03-07 |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-03-04 |
Jefferies | Reiterated | Hold | 2023-03-07 |
JP Morgan | Upgraded | Underweight → Neutral | 2021-01-29 |
Wedbush | Downgraded | Outperform → Neutral | 2021-01-29 |
Gabelli & Co. | Upgraded | Hold → Buy | 2020-11-18 |
Stifel Nicolaus | Downgraded | Buy → Hold | 2019-07-29 |
Stifel | Downgraded | Buy → Hold | 2019-07-29 |
H.C. Wainwright | Reiterated | Buy | 2016-10-07 |
Bank of America | Reiterated | Underperform | 2013-12-06 |
Morgan Stanley | Downgraded | Equal Weight → Underweight | 2013-06-11 |
One row per institution, most recent rating